Abbott Labs Files Q3 2024 10-Q
Ticker: ABT · Form: 10-Q · Filed: 2024-10-31T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
Related Tickers: ABT
TL;DR
ABT's Q3 10-Q is in - check financials for latest performance.
AI Summary
Abbott Laboratories filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter and the first nine months of the year. Key financial metrics and business segment information are provided, reflecting the company's ongoing activities in the pharmaceutical and medical device sectors.
Why It Matters
This filing provides investors with the latest financial results and operational details for Abbott Laboratories, crucial for understanding the company's performance and future outlook.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial disclosures.
Key Players & Entities
- ABBOTT LABORATORIES (company) — Filer
- 0000001800 (company) — Central Index Key
- 20240930 (date) — Period of Report
- 20241031 (date) — Filed as of Date
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20240930, meaning the filing covers the period ending September 30, 2024.
What is the company's Central Index Key (CIK)?
The Central Index Key for Abbott Laboratories is 0000001800.
When was this 10-Q filing submitted?
The filing was submitted on 20241031.
What is the Standard Industrial Classification (SIC) code for Abbott Laboratories?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's state of incorporation?
Abbott Laboratories is incorporated in Illinois (IL).
From the Filing
0001628280-24-044602.txt : 20241031 0001628280-24-044602.hdr.sgml : 20241031 20241031171400 ACCESSION NUMBER: 0001628280-24-044602 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 75 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241031 DATE AS OF CHANGE: 20241031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 241416158 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 10-Q 1 abt-20240930.htm 10-Q abt-20240930 0000001800 12-31 2024 Q3 false P12M xbrli:shares iso4217:USD iso4217:USD xbrli:shares abt:segment xbrli:pure abt:intangibleAsset iso4217:JPY iso4217:EUR 0000001800 2024-01-01 2024-09-30 0000001800 exch:XCHI 2024-01-01 2024-09-30 0000001800 exch:XNYS 2024-01-01 2024-09-30 0000001800 2024-09-30 0000001800 2024-07-01 2024-09-30 0000001800 2023-07-01 2023-09-30 0000001800 2023-01-01 2023-09-30 0000001800 2023-12-31 0000001800 us-gaap:CommonStockMember 2024-06-30 0000001800 us-gaap:CommonStockMember 2023-06-30 0000001800 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0000001800 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000001800 us-gaap:CommonStockMember 2024-09-30 0000001800 us-gaap:CommonStockMember 2023-09-30 0000001800 us-gaap:TreasuryStockCommonMember 2024-06-30 0000001800 us-gaap:TreasuryStockCommonMember 2023-06-30 0000001800 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-30 0000001800 us-gaap:TreasuryStockCommonMember 2023-07-01 2023-09-30 0000001800 us-gaap:TreasuryStockCommonMember 2024-09-30 0000001800 us-gaap:TreasuryStockCommonMember 2023-09-30 0000001800 us-gaap:RetainedEarningsMember 2024-06-30 0000001800 us-gaap:RetainedEarningsMember 2023-06-30 0000001800 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0000001800 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000001800 us-gaap:RetainedEarningsMember 2024-09-30 0000001800 us-gaap:RetainedEarningsMember 2023-09-30 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000001800 us-gaap:NoncontrollingInterestMember 2024-06-30 0000001800 us-gaap:NoncontrollingInterestMember 2023-06-30 0000001800 us-gaap:NoncontrollingInterestMember 2024-07-01 2024-09-30 0000001800 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0000001800 us-gaap:NoncontrollingInterestMember 2024-09-30 0000001800 us-gaap:NoncontrollingInterestMember 2023-09-30 0000001800 us-gaap:CommonStockMember 2023-12-31 0000001800 us-gaap:CommonStockMember 2022-12-31 0000001800 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0000001800 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0000001800 us-gaap:TreasuryStockCommonMember 2023-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2022-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-09-30 0000001800 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-09-30 0000001800 us-gaap:RetainedEarningsMember 2023-12-31 0000001800 us-gaap:RetainedEarningsMember 2022-12-31 0000001800 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-30 0000001800 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 00000